Research Article
Preparation and MRI Study of HER2-Targeted Bimodal Molecular Probe Gd-Cy5.5-Pertuzumab for Thyroid Cancer
Figure 2
(a) Gd-Cy5.5-pertuzumab nanoprobe hydration particle size; (b) Gd-Cy5.5-pertuzumab nanoprobe zeta potential.
| (a) |
| (b) |
| (a) |
| (b) |